Pheromone Sciences Corp has commenced a advanced testing of its proprietary sensing technology for large animal breeding at the Ontario Veterinary College, University of Guelph, under the direction of Dr. Walter Johnson. This testing is designed to generate core data required to fully adapt the Company's PSC Fertility Monitor for use in detecting hormone and ovulation patterns in dairy cows. This work is scheduled to be completed at the end of Q3.
As part of this effort, the company is pleased to announce the engagement of Dr. Linda Rhodes VMD, PhD as consultant to help design and manage the best possible clinical program for the animal breeding technology. Within this ongoing program, the Company looks to generate efficacy and economic data for use by the target market. Dr Rhodes' experience combines over 23 years in dairy cattle veterinary practice, research in reproductive physiology, and human and animal drug discovery and development. Dr. Rhodes has experience with designing and executing clinical trials and leading product development teams in the veterinary pharmaceutical industry.
"We are very excited about this next stage of the development process for our PSC Fertility Monitor technology and continue tracking toward completion of this agricultural program next year." said Christopher Neuman, President and CEO of Pheromone Sciences.
This novel program is based on the same core technology employed within the FDA approved PSC Fertility Monitor for human use. Successful completion of the agricultural program next year would create a non-invasive, safe and easy to use fertility and ovulation detection device for use in cattle breeding operations. Currently, some US$400 million is lost each year in North America due to timing issues in breeding dairy herds.